{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:34Z","timestamp":1786120294820,"version":"build-2736575974"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/adm.0b013e3182312983","type":"journal-article","created":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T08:56:33Z","timestamp":1319878593000},"page":"254-263","source":"Crossref","is-referenced-by-count":92,"title":["Statement of the American Society of Addiction Medicine Consensus Panel on the Use of Buprenorphine in Office-Based Treatment of Opioid Addiction"],"prefix":"10.1097","volume":"5","author":[{"given":"Mark L.","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Alford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Kotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Levounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin A.","family":"Salsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Wetterau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"R1-3-20210126","first-page":"460","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy Review. Ann Intern Med 2006;144(2):127-134.","volume":"144","author":"Alford","year":"2006","journal-title":"Erratum in Ann Intern Med"},{"key":"R4-3-20210126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.","volume":"28","author":"Amato","year":"2005","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"R5-3-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ewjm.172.1.43","article-title":"Use of methadone.","volume":"172","author":"Anderson","year":"2000","journal-title":"West J Med"},{"issue":"1","key":"R6-3-20210126","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/jhep.2001.25882","article-title":"Treatment of hepatitis C infection in injection drug users.","volume":"34","author":"Backmund","year":"2001","journal-title":"Hepatology"},{"issue":"1-3","key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2007.09.018","article-title":"Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.","volume":"94","author":"Becker","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R10-3-20210126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0168-8278(00)00049-0","article-title":"Hepatitis after intravenous buprenorphine misuse in heroin addicts.","volume":"34","author":"Berson","year":"2001","journal-title":"J Hepatol"},{"issue":"5","key":"R14-3-20210126","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.aids.0000216384.22432.9a","article-title":"Three case reports of a clinical pharmacokinetic interaction between buprenorphine and atazanavir plus ritonavir.","volume":"20","author":"Bruce","year":"2006","journal-title":"AIDS"},{"issue":"2","key":"R15-3-20210126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/09595230600681527","article-title":"A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance Review.","volume":"25","author":"Caplehorn","year":"2006","journal-title":"Drug Alcohol Rev"},{"key":"R16-3-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0376-8716(00)80007-1","article-title":"Use of buprenorphine in HIV infected injection drug users: negligible impact on virological response to HAART. The Manif-2000 Study Group.","volume":"60","author":"Carrieri","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0755-4982(05)84025-4","article-title":"Infectious complications and misuse of high-dose buprenorphine.","volume":"34","author":"Cazorla","year":"2005","journal-title":"Presse Med"},{"issue":"7","key":"R21-3-20210126","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3949\/ccjm.74.7.514","article-title":"Buprenorphine maintenance: a new treatment for opioid dependence.","volume":"74","author":"Collins","year":"2007","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"R22-3-20210126","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1124\/jpet.105.090423","article-title":"Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals.","volume":"315","author":"Comer","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00213-005-0023-6","article-title":"Buprenorphinenaloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.","volume":"181","author":"Comer","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl","key":"R24-3-20210126","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1111\/j.1360-0443.1996.tb02338.x","article-title":"Looking forward and back to relapse: implications for research and practice.","volume":"91","author":"Connors","year":"1996","journal-title":"Addiction"},{"issue":"11","key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1176\/ajp.155.11.1611","article-title":"Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study.","volume":"155","author":"Daley","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R27-3-20210126","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00005053-200301000-00003","article-title":"Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse.","volume":"191","author":"Dausey","year":"2003","journal-title":"J Nerv Ment Dis"},{"issue":"5","key":"R29-3-20210126","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2044.1979.tb06325.x","article-title":"Analgesic effects of sublingual buprenorphine.","volume":"34","author":"Edge","year":"1979","journal-title":"Anaesthesia"},{"issue":"2","key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/ADM.0b013e3180473c11","article-title":"The first three years of buprenorphine in the United States: experience to date and future directions.","volume":"1","author":"Fiellin","year":"2007","journal-title":"J Addict Med"},{"issue":"17","key":"R31-3-20210126","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.2008.567","article-title":"Treatment of adolescent opioid dependence: no quick fix.","volume":"300","author":"Fiellin","year":"2008","journal-title":"JAMA"},{"issue":"Suppl 4","key":"R32-3-20210126","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1086\/508180","article-title":"Opioid dependence: rationale for and efficacy of existing and new treatments Review.","volume":"43","author":"Fiellin","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphinenaloxone in primary care: results at 2-5 years.","volume":"17","author":"Fiellin","year":"2008","journal-title":"Am J Addict"},{"issue":"8","key":"R35-3-20210126","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1526-4637.2008.00491.x","article-title":"Reported lifetime drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.","volume":"9","author":"Fleming","year":"2008","journal-title":"Pain Med"},{"issue":"2","key":"R37-3-20210126","first-page":"CD002025","article-title":"Buprenorphine for the management of opioid withdrawal Review.","author":"Gowing","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"R38-3-20210126","first-page":"CD002025","article-title":"Buprenorphine for the management of opioid withdrawal Review.","author":"Gowing","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"R39-3-20210126","first-page":"99","article-title":"Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches CNS D","volume":"22","author":"Gunderson","year":"2008","journal-title":"rugs"},{"issue":"1","key":"R40-3-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1360-0443.2008.02411.x","article-title":"Substance use disorder among older adults in the United States in 2020.","volume":"104","author":"Han","year":"2009","journal-title":"Addiction"},{"issue":"2","key":"R42-3-20210126","doi-asserted-by":"crossref","first-page":"225","DOI":"10.36076\/ppj.2008\/11\/225","article-title":"Opioid antagonists, partial agonists, and agonistsantagonists: the role of office-based detoxification Review.","volume":"11","author":"Helm","year":"2008","journal-title":"Pain Physician"},{"issue":"Suppl 2","key":"R43-3-20210126","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","article-title":"Use of buprenorphine in pregnancy: patient management and effects on the neonate.","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl","key":"R44-3-20210126","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: how to use it right.","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R45-3-20210126","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after Methadone or Buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"R46-3-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Dependence"},{"issue":"3","key":"R47-3-20210126","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependent pregnant women: clinical and research issues.","volume":"35","author":"Jones","year":"2008","journal-title":"J Subst Abus Treat"},{"issue":"5-6","key":"R48-3-20210126","first-page":"347","article-title":"Methadone maintenance treatment (MMT): a review of historical and clinical issues Review.","volume":"67","author":"Joseph","year":"2000","journal-title":"Mt Sinai J Med"},{"issue":"1-2","key":"R49-3-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2008.01.025","article-title":"Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.","volume":"96","author":"Kakka","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R50-3-20210126","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice.","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R51-3-20210126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States.","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"R52-3-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/08897070802218661","article-title":"Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.","volume":"29","author":"Khalsa","year":"2008","journal-title":"Subst Abus"},{"issue":"4","key":"R53-3-20210126","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2007.9.4\/hkleber","article-title":"Pharmacologic treatments for opioid dependence: detoxification and maintenance options Review.","volume":"9","author":"Kleber","year":"2007","journal-title":"Dialogues Clin Neurosci"},{"key":"R54-3-20210126","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1360-0443.2010.03170.x","article-title":"Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.","volume":"106","author":"Kraft","year":"2011","journal-title":"Addiction"},{"issue":"1-3","key":"R55-3-20210126","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","article-title":"Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.","volume":"99","author":"Lavie","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"5-6","key":"R56-3-20210126","first-page":"404","article-title":"When enough is not enough: new perspectives on optimal methadone maintenance dose Review.","volume":"67","author":"Leavitt","year":"2000","journal-title":"Mt Sinai J Med"},{"issue":"3","key":"R57-3-20210126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Aubisson S; Groupe dEtudes Grossesse et Addictions (GEGA). Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution.","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"R58-3-20210126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jadohealth.2006.11.142","article-title":"Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a childrens hospital-based outpatient treatment program.","volume":"40","author":"Levy","year":"2007","journal-title":"J Adolesc Health"},{"key":"R60-3-20210126","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents.","volume":"62","author":"Marsch","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"R62-3-20210126","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1086\/429503","article-title":"Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: The importance of drug interactions between opioids and antiretroviral agents.","volume":"41","author":"McCance-Katz","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"R63-3-20210126","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/508187","article-title":"Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"R64-3-20210126","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1086\/508188","article-title":"Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavirritonavir, and ritonavir.","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"R66-3-20210126","first-page":"12","article-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction.","volume":"1","author":"McNicholas","year":"2008","journal-title":"A Tool for Buprenorphine Care"},{"issue":"1","key":"R67-3-20210126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-6576.1990.tb03044.x","article-title":"Sublingual buprenorphine as postoperative analgesic: a double-blind comparison with pethidine.","volume":"34","author":"Moa","year":"1990","journal-title":"Acta Anaesthesiol Scand"},{"key":"R68-3-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00002030-200001280-00010","article-title":"Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 Study Group.","volume":"4","author":"Moatti","year":"2000","journal-title":"AIDS"},{"issue":"9","key":"R70-3-20210126","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States.","volume":"15","author":"Paulozzi","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"R71-3-20210126","first-page":"188","article-title":"Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients J Clin P","volume":"27","author":"Reed","year":"2007","journal-title":"sychopharmacol"},{"issue":"9","key":"R75-3-20210126","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20675","article-title":"Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain.","volume":"56","author":"Sanchez","year":"2008","journal-title":"Glia"},{"issue":"5","key":"R76-3-20210126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hup.698","article-title":"Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002.","volume":"20","author":"Schifano","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"R77-3-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2003.00245.x","article-title":"Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy.","volume":"98","author":"Schindler","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"R78-3-20210126","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jsat.2009.05.003","article-title":"Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.","volume":"37","author":"Soeffing","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"R79-3-20210126","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/10550880902772431","article-title":"Epidemiological trends in abuse and misuse of prescription opioids.","volume":"28","author":"Spiller","year":"2009","journal-title":"J Addict Dis"},{"issue":"5","key":"R80-3-20210126","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.annemergmed.2003.11.006","article-title":"Buprenorphine: a primer for emergency physicians.","volume":"43","author":"Sporer","year":"2004","journal-title":"Ann Emerg Med"},{"issue":"11","key":"R83-3-20210126","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy.","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"R84-3-20210126","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1360-0443.2007.02056.x","article-title":"Gender and non-medical use of prescription opioids: results from a national US survey.","volume":"103","author":"Tetrault","year":"2008","journal-title":"Addiction"},{"issue":"5","key":"R86-3-20210126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.jcp.0000138766.15858.c6","article-title":"Effects of high-dose intravenous buprenorphine in experienced opioid abusers.","volume":"24","author":"Umbricht","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R87-3-20210126","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1360-0443.2011.03440.x","article-title":"Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.","volume":"106","author":"Unger","year":"2011","journal-title":"Addiction"},{"issue":"4","key":"R88-3-20210126","first-page":"247","article-title":"The effect of substitution therapy on the birth weight of the newborn, its postpartum adaptation, trophic and course of the neonatal abstinence syndrome.","volume":"72","author":"Vavrinkova","year":"2007","journal-title":"Ceska Gynekol"},{"key":"R89-3-20210126","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"key":"R90-3-20210126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsat.2007.04.015","article-title":"Addiction recovery: its definition and conceptual boundaries.","volume":"33","author":"White","year":"2007","journal-title":"J Subst Abuse Treat"},{"issue":"17","key":"R91-3-20210126","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01271255-201112000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:28:08Z","timestamp":1786048088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01271255-201112000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e3182312983","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}